Trade Summary

2 days ago, Dolan Oliver, serving as Senior Vice President, Finance at Korro Bio, Inc. (KRRO), sold 3,383 shares at $10.83 per share, for a total transaction value of $36,637.89. Following this transaction, Dolan Oliver now holds 18,099 shares of KRRO.

This sale represents a 15.75% decrease in Dolan Oliver's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 4:05 PM ET, 1 day after the trade was made.

Korro Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.